BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 19120280)

  • 21. Therapeutic applications of nucleic acids as ligands for Toll-like receptors.
    Panter G; Kuznik A; Jerala R
    Curr Opin Mol Ther; 2009 Apr; 11(2):133-45. PubMed ID: 19330719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The significance of toll-like receptors in human diseases.
    Montero Vega MT; de Andrés Martín A
    Allergol Immunopathol (Madr); 2009; 37(5):252-63. PubMed ID: 19853360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal Toll-like receptors: recent advances and implications for disease.
    El-Achkar TM; Dagher PC
    Nat Clin Pract Nephrol; 2006 Oct; 2(10):568-81. PubMed ID: 17003836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleic acid recognition receptors in autoimmunity.
    Krug A
    Handb Exp Pharmacol; 2008; (183):129-51. PubMed ID: 18071658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Innate immune response to viral infection.
    Koyama S; Ishii KJ; Coban C; Akira S
    Cytokine; 2008 Sep; 43(3):336-41. PubMed ID: 18694646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of innate immunity in the induction of autoimmunity.
    Pisetsky DS
    Autoimmun Rev; 2008 Oct; 8(1):69-72. PubMed ID: 18708168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptors in autoimmunity.
    Fischer M; Ehlers M
    Ann N Y Acad Sci; 2008 Nov; 1143():21-34. PubMed ID: 19076342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type I interferons and the innate immune response--more than just antiviral cytokines.
    Smith PL; Lombardi G; Foster GR
    Mol Immunol; 2005 May; 42(8):869-77. PubMed ID: 15829276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendritic cell subsets and toll-like receptors.
    Hochrein H; O'Keeffe M
    Handb Exp Pharmacol; 2008; (183):153-79. PubMed ID: 18071659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Innate and adaptive immune pathways to tolerance.
    Thornton CA; Morgan G
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell activation by TLRs: a role for TLRs in the adaptive immune response.
    MacLeod H; Wetzler LM
    Sci STKE; 2007 Sep; 2007(402):pe48. PubMed ID: 17785715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvants and autoimmunity.
    Israeli E; Agmon-Levin N; Blank M; Shoenfeld Y
    Lupus; 2009 Nov; 18(13):1217-25. PubMed ID: 19880572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innate sensing of self and non-self RNAs by Toll-like receptors.
    Sioud M
    Trends Mol Med; 2006 Apr; 12(4):167-76. PubMed ID: 16530484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate control of adaptive immunity: dendritic cells and beyond.
    Lee HK; Iwasaki A
    Semin Immunol; 2007 Feb; 19(1):48-55. PubMed ID: 17276695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes.
    Kopp A; Buechler C; Neumeier M; Weigert J; Aslanidis C; Schölmerich J; Schäffler A
    Obesity (Silver Spring); 2009 Apr; 17(4):648-56. PubMed ID: 19148127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance.
    Ehlers M; Ravetch JV
    Trends Immunol; 2007 Feb; 28(2):74-9. PubMed ID: 17197239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Platelets "Toll-like receptor" engagement stimulates the release of immunomodulating molecules].
    Cognasse F; Hamzeh-Cognasse H; Garraud O
    Transfus Clin Biol; 2008 Sep; 15(4):139-47. PubMed ID: 18842435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Innate immunity and tuberculosis].
    Uematsu S; Akira S
    Kekkaku; 2008 Feb; 83(2):101-9. PubMed ID: 18326337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.
    Devilder MC; Allain S; Dousset C; Bonneville M; Scotet E
    J Immunol; 2009 Sep; 183(6):3625-33. PubMed ID: 19710464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TLRs are important inflammatory factors in atherosclerosis and may be a therapeutic target.
    Liu Y; Yu H; Zhang Y; Zhao Y
    Med Hypotheses; 2008; 70(2):314-6. PubMed ID: 17689203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.